2010-03-08

Olink Bioscience and Multisciences Biotech sign distributorship agreement for the Chinese market.

Olink Bioscience and Multisciences Biotec sign distributorship agreement for the Chinese market.


UPPSALA, SWEDEN, March 8, 2010Olink Bioscience has signed a distributorship agreement with the Chinese distributor Multisciences Biotech Co., Ltd for distribution of the Duolink® product line in China.

Multisciences Biotech, a widely recognized company for its high quality technical support, professionalism, and distribution network, is an ideal partner for Olink Bioscience to bring Duolink to the research community in China.” says Peter Karlberg, Director of Sales and Marketing at Olink Bioscience.

“We believe that the unique and enabling Duolink product line fits perfectly with the line of products distributed by Multisciences Biotech and will help us in our aim to offer our customers a broad portfolio of high qualitative products for research and diagnostics” says Xie Yan, Vice President of MultiSciences Biotech.

The Duolink product line is based on Olink Bioscience proprietary in situ PLA® a proximity ligation assay technology that extends the capabilities of traditional protein techniques to include direct detection of proteins, protein interactions and modifications with unparalleled specificity and sensitivity. Target proteins are detected with single molecule resolution, allowing digital quantification and information about the exact localization of the target. Furthermore, the proteins can be studied at normal expression levels in fixed cells and tissue sections.

 

About Olink Bioscience

Olink Bioscience, founded in 2004, is based on a strong intellectual property portfolio focused towards the development of cutting-edge technologies for biomolecular analysis in research and diagnostics. The company’s proprietary Duolink product line enables researchers in academia and the pharmaceutical industry to visualize and accurately quantify individual proteins, their interactions and modifications, in unmodified cells and tissues. Such information is crucial to help elucidate disease mechanisms, leading to the development of novel diagnostics and therapeutics. The Duolink line is marketed and sold through a growing distributor network. A second revenue stream comes from the out-licensing of other proprietary technologies to major biotech supply companies. Olink Bioscience is a privately held company headquartered in Uppsala, Sweden.

Duolink is intended for research use only. Duolink is not for use in human diagnostic or therapeutic procedures.

 

About Multisciences Biotech

MultiSciences Biotech Ltd headquartered in Hangzhou was established in March 2001 and has become the most well-known reagent and equipment supplier for immunology and cell biology in China. With six branch offices covering East China, North China, South China, Central China and Southeast China respectively, timely and efficient customer support and logistics service is ensured. MultiSciences has established a number of exclusive and regional distributorship agreements with global bio-manufacturers, providing a wide range of high quality products to Chinese customers. The aim is to act as a total solution provider and introduce new and innovative technologies and products to the Chinese customers. To serve the customers MultiSciences offers a 24 hour toll free hot line, a dedicated mailbox (service@gotofcm.com)  for technical support and a web site (www.gotofcm.com), where customers can access the latest updated information.

 

For information please contact:

 

Peter Karlberg

Director Sales and Marketing

Olink Bioscience

Phone: +46 (0)18 444 30 70

Email: peter.karlberg@olink.com

 

Xie Yan

Vice President

Multisciences Biotec co., Ltd

Phone: 86 21 64132459

Email: xy@gotofcm.com

 


Pressmeddelandet skickades med MyNewsdesk

CONTACT WEBMASTER | SHARE